Ads
related to: remicade generic equivalentgoodrx.com has been visited by 100K+ users in the past month
Working to be "the most powerful patient advocate in America" - Forbes
Search results
Results from the WOW.Com Content Network
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease , ulcerative colitis , rheumatoid arthritis , ankylosing spondylitis , psoriasis , psoriatic arthritis , and Behçet's disease . [ 23 ]
he first rule of investing in pharmaceuticals is that when a drug loses patent protection, the drug maker loses sales. Remsima, a biosimilar version of Remicade, has been on sale in Korea since ...
An FDA advisory committee just gave a recommendation for a version of Remicade, a drug used to treat autoimmune diseases. A new drug that could save the US billions of dollars just got one step ...
Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab.
Hospira announced that the European Commission has approved its biosimilar version of Remicade from Johnson & Johnson and Merck . The approval of the new drug, called Inflectra, marks the first ...
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International Nonproprietary Name
This drug can cause the patient to develop antibodies to the medicine itself, which are termed HACAs. The incidence of developing these antibodies is highest in patients receiving intermittent therapy with infliximab, and lowest in patient receiving continuous therapy and concomitant immunosuppressive therapy .
Billions of dollars are spent annually on researching and developing drugs, but the truth of the matter, according to Medscape, is that just one out of every 5,000 to 10,000 compounds studied in ...